Clinical Trial Update: Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating the safety and feasibility of using allogeneic mesenchymal stromal stem cells to treat radiation-induced xerostomia in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-induced Xerostomia

Drugs mentioned

• Allogeneic mesenchymal stromal stem cells (mesenchymal stromal stem cells)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Radiation-Induced Xerostomia, Head and Neck Cancer | Phase 1 | Status: COMPLETED